This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Energizer (ENR) Beats on Q2 Earnings, Raises FY22 Sales View
by Zacks Equity Research
Solid performance across the auto care business boosts Energizer's (ENR) second-quarter fiscal 2022 sales results. Management repeats its EPS outlook for the current fiscal year.
Coty (COTY) Stock Down Despite Q3 Earnings Beat & Raised View
by Zacks Equity Research
Coty's (COTY) third-quarter fiscal 2022 results reflect higher earnings and revenues on growth across all regions and channels. However, rising inflation and supply pressure are headwinds.
Sysco (SYY) Beats on Q3 Earnings & Sales, Raises EPS View
by Zacks Equity Research
Sysco's (SYY) third-quarter fiscal 2022 results reflect increased top and bottom lines. The company benefits from its Recipe for Growth plan and efforts to manage cost inflation.
Archer Daniels (ADM) Displays Strength: Stock Rally to Continue
by Zacks Equity Research
Archer Daniels (ADM) continues to gain from robust demand, product innovation, strength in the Nutrition segment and improved productivity.
Sysco (SYY) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sysco (SYY) delivered earnings and revenue surprises of 31.48% and 5.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TreeHouse Foods (THS) Q1 Loss Narrower Than Expected, Stock Up
by Zacks Equity Research
TreeHouse Foods' (THS) Q1 results reflect high demand for private label consumption and solid pricing actions to counter inflation, while volumes bear the brunt of labor and supply-chain woes.
Tyson Foods (TSN) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) second-quarter fiscal 2022 sales and earnings rise year over year on the back of gains across all the segments. Management raises fiscal 2022 sales view.
Post Holdings (POST) Stock Up More Than 5% Since Q2 Earnings
by Zacks Equity Research
Post Holdings' (POST) second-quarter fiscal 2022 results reflect higher earnings and sales. While buyouts and continued foodservice recovery have been upsides, elevated costs have been a concern.
Factors to Note as Sysco (SYY) Queues Up for Q3 Earnings
by Zacks Equity Research
Sysco Corporation's (SYY) third-quarter results are likely to reflect gains from the Recipe for Growth program and acquisitions, while high labor costs are concerning.
Hain Celestial's (HAIN) Q3 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports weak performance in third-quarter fiscal 2022 on high inflations, supply-chain disruptions, ingredient and package shortages.
B&G Foods (BGS) Q1 Earnings Miss Estimates, EPS View Lowered
by Zacks Equity Research
B&G Foods' (BGS) first-quarter fiscal 2022 results reflect gains from high demand and pricing actions, whereas the escalated input cost inflation hurts margins.
AB InBev (BUD) Surpasses Sales & Earnings Estimates in Q1
by Zacks Equity Research
AB InBev's (BUD) Q1 results reflect continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
Kellogg's (K) Q1 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg Company's (K) first-quarter 2022 results reflect higher sales, thanks to strength in snacks and solid price/mix. Earnings were hurt by increased cost inflation and other business hurdles.
Hain Celestial (HAIN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -28.26% and 4.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medifast (MED) Tops Q1 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Medifast's (MED) first-quarter 2022 results reflect increased earnings and revenues owing to continued strength in OPTAVIA. Management raises sales and earnings view for 2022.
Should You Invest in the Invesco Dynamic Leisure and Entertainment ETF (PEJ)?
by Zacks Equity Research
Sector ETF report for PEJ
Sysco (SYY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Sysco (SYY) closed at $85.76, marking a +0.73% move from the previous day.
The Estee Lauder Companies (EL) Beats on Earnings in Q3
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter fiscal 2022 sales and earnings rise year over year on growth in every product category. Management lowered fiscal 2022 view.
Molson Coors (TAP) Q1 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Molson Coors' (TAP) Q1 results reflect continued progress on its revitalization plan, premiumization efforts and strength in core brands. However, inflationary pressure remains concerning.
Clorox (CLX) Q3 Earnings & Sales Beat on Solid Demand
by Zacks Equity Research
Clorox (CLX) Q3 results gained from solid demand, pricing actions and cost savings efforts. However, the ongoing inflationary pressures led to lowered bottom line view for fiscal 2022.
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, The Chefs' Warehouse, Pilgrim's Pride, McCormick & Company and Sysco
by Zacks Equity Research
Archer-Daniels-Midland, The Chefs' Warehouse, Pilgrim's Pride, McCormick & Company and Sysco have been included in this Analyst Blog.
Clorox (CLX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 35.05% and 0.04%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Picks for May From Best S&P 500 Sectors in Ruthless April
by Nalak Das
We have narrowed our search to five consumer staples stocks that have solid growth potential for the rest of 2022. These are: PPC, ADM, CHEF, MKC and SYY.
Keurig Dr Pepper (KDP) Q1 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper (KDP) reports solid sales performance for first-quarter 2022 on gains from its robust brand portfolio. KDP raises sales view for the year.
Colgate (CL) Meets Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Colgate's (CL) Q1 results reflect soft bottom-line performance on higher raw material and logistics costs despite the increased top line. Margins remain soft.